Dr. Hibba Tul Rehman
Claim this profileCentral Vermont Medical Center/National Life Cancer Treatment
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage I
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Hibba Tul Rehman is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
More about Hibba Tul Rehman
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Hibba Tul Rehman has experience with
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Crizotinib
- Screening Platform
- Ramucirumab
Breakdown of trials Hibba Tul Rehman has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hibba Tul Rehman specialize in?
Hibba Tul Rehman focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage I.
Is Hibba Tul Rehman currently recruiting for clinical trials?
Yes, Hibba Tul Rehman is currently recruiting for 4 clinical trials in Berlin Vermont. If you're interested in participating, you should apply.
Are there any treatments that Hibba Tul Rehman has studied deeply?
Yes, Hibba Tul Rehman has studied treatments such as Pembrolizumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Hibba Tul Rehman?
Apply for one of the trials that Hibba Tul Rehman is conducting.
What is the office address of Hibba Tul Rehman?
The office of Hibba Tul Rehman is located at: Central Vermont Medical Center/National Life Cancer Treatment, Berlin, Vermont 05602 United States. This is the address for their practice at the Central Vermont Medical Center/National Life Cancer Treatment.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.